Growth Metrics

Boston Scientific (BSX) Total Current Liabilities (2016 - 2025)

Boston Scientific (BSX) has disclosed Total Current Liabilities for 17 consecutive years, with $5.4 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 15.0% to $5.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 billion through Dec 2025, down 15.0% year-over-year, with the annual reading at $5.4 billion for FY2025, 15.0% down from the prior year.
  • Total Current Liabilities hit $5.4 billion in Q4 2025 for Boston Scientific, up from $5.3 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $6.4 billion in Q4 2024 to a low of $3.4 billion in Q1 2021.
  • Historically, Total Current Liabilities has averaged $4.7 billion across 5 years, with a median of $4.6 billion in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 31.05% in 2021 and later decreased 15.0% in 2025.
  • Year by year, Total Current Liabilities stood at $4.3 billion in 2021, then decreased by 11.02% to $3.8 billion in 2022, then rose by 29.71% to $4.9 billion in 2023, then increased by 29.72% to $6.4 billion in 2024, then dropped by 15.0% to $5.4 billion in 2025.
  • Business Quant data shows Total Current Liabilities for BSX at $5.4 billion in Q4 2025, $5.3 billion in Q3 2025, and $5.2 billion in Q2 2025.